LENSAR, INC. Operating Cash Flow
LENSAR, INC. (LNSR) reported Operating Cash Flow of -$4.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- LENSAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$127.00K.
- LENSAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.27M.
- LENSAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $618.00K, a 83.10% decline year-over-year.
- LENSAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.51M, a 211.42% decline year-over-year.
- LENSAR, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$14.83M.
- LENSAR, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.27M.
- LENSAR, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$9.66M.
- LENSAR, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$14.86M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.40M 10-Q · filed 2026-08-13 | -$3.78M derived: sum of 3 quarters · filed 2026-08-13 | -$7.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$4.27M 10-Q · filed 2026-05-08 | -$3.65M derived: sum of 2 quarters · filed 2026-05-08 | -$7.17M derived: sum of 3 quarters · filed 2026-05-08 | -$12.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.90M derived: sum of 2 quarters · filed 2026-03-31 | -$7.89M derived: sum of 3 quarters · filed 2026-08-13 | -$14.83M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.51M derived: sum of 2 quarters · filed 2026-08-13 | -$15.45M 10-Q · filed 2025-11-06 | -$11.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$11.94M 10-Q · filed 2026-08-13 | -$8.28M derived: sum of 3 quarters · filed 2026-08-13 | -$5.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$6.94M 10-Q · filed 2026-05-08 | -$3.28M derived: sum of 2 quarters · filed 2026-05-08 | -$128.00K derived: sum of 3 quarters · filed 2026-05-08 | -$3.91M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $6.81M derived: sum of 2 quarters · filed 2026-03-31 | $3.03M derived: sum of 3 quarters · filed 2026-03-31 | -$2.27M 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$625.00K derived: sum of 2 quarters · filed 2025-11-06 | -$5.93M 10-Q · filed 2025-11-06 | -$6.41M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$9.09M 10-Q · filed 2025-08-07 | -$9.56M derived: sum of 3 quarters · filed 2025-08-07 | -$9.90M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$5.31M 10-Q · filed 2025-05-08 | -$5.79M derived: sum of 2 quarters · filed 2025-05-08 | -$6.13M derived: sum of 3 quarters · filed 2025-05-08 | -$8.27M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$819.00K derived: sum of 2 quarters · filed 2025-02-27 | -$2.96M derived: sum of 3 quarters · filed 2025-02-27 | -$9.66M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.48M derived: sum of 2 quarters · filed 2024-11-07 | -$9.18M 10-Q · filed 2024-11-07 | -$13.94M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$8.84M 10-Q · filed 2024-08-08 | -$13.60M derived: sum of 3 quarters · filed 2024-08-08 | -$18.30M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$6.70M 10-Q · filed 2024-05-09 | -$11.45M derived: sum of 2 quarters · filed 2024-05-09 | -$16.16M derived: sum of 3 quarters · filed 2024-05-09 | -$18.95M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$9.46M derived: sum of 2 quarters · filed 2024-03-04 | -$12.25M derived: sum of 3 quarters · filed 2024-03-04 | -$14.86M 10-K · filed 2024-03-04 |
| 2022-09-30 | -$4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$7.49M derived: sum of 2 quarters · filed 2023-11-09 | -$10.10M 10-Q · filed 2023-11-09 | -$10.84M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$5.40M 10-Q · filed 2023-08-09 | -$6.14M derived: sum of 3 quarters · filed 2023-08-09 | -$8.29M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$2.61M 10-Q · filed 2023-05-15 | -$3.35M derived: sum of 2 quarters · filed 2023-05-15 | -$5.50M derived: sum of 3 quarters · filed 2023-05-15 | -$6.96M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$2.89M derived: sum of 2 quarters · filed 2023-03-16 | -$4.35M derived: sum of 3 quarters · filed 2023-03-16 | -$8.97M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.61M derived: sum of 2 quarters · filed 2022-11-09 | -$8.23M 10-Q · filed 2022-11-09 | -$10.23M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$6.08M 10-Q · filed 2022-08-08 | -$8.08M derived: sum of 3 quarters · filed 2022-08-08 | -$8.13M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$4.62M 10-Q · filed 2022-05-09 | -$6.62M derived: sum of 2 quarters · filed 2022-05-09 | -$6.67M derived: sum of 3 quarters · filed 2022-05-09 | -$12.05M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$2.05M derived: sum of 2 quarters · filed 2022-03-03 | -$7.43M derived: sum of 3 quarters · filed 2022-03-03 | -$13.79M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$5.43M derived: sum of 2 quarters · filed 2021-11-08 | -$11.79M 10-Q · filed 2021-11-08 | -$18.57M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$11.74M 10-Q · filed 2021-08-06 | -$18.52M derived: sum of 3 quarters · filed 2021-08-06 | |
| 2020-03-31 | -$6.36M 10-Q · filed 2021-05-06 | -$13.14M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$6.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$12.59M 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$5.81M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |